Developer site: The content shown here is test data.

Health Dictionary AI Health Chat Find an Online Doctor
A serene Zen garden with raked sand and smooth stones, symbolising clarity and calm

Health Dictionary

Back to skin conditions

Helicobacter pylori infection pathophysiology

Introduction

Overview

Overview

The precise mode of transmission of Helicobacter pylori is most likely considered to be through fecal-oral and oral-oral routes, largely through intrafamilial spread (particularly mother-to-child). H. pylori is a noninvasive organism. It is found within the mucus layer overlying surface epithelial cells and also deep within gastric glands, where it interacts with gland base stem/progenitor cells. It colonizes gastric-type epithelium only; it does not colonize normal squamous esophagus or normal duodenal mucosa, but can colonize foci of gastric metaplasia. Chronic infection is the strongest risk factor for non-cardia gastric adenocarcinoma and drives gastric mucosa-associated lymphoid tissue (MALT) lymphoma. Pathogenesis of H. pylori infection depends on bacterial, host and environmental factors.

Pathophysiology

Pathophysiology

  • The precise mode of transmission of H. pylori remains unclear.[1][2][3]
  • Fecal-oral and oral-oral routes, largely through intrafamilial spread (particularly mother-to-child), are considered the most likely modes of transmission.[4][5]
  • It is almost always acquired during childhood and infection is lifelong if left untreated.[6]
  • Helicobacter pylori is usually transmitted via the following routes:
  • Oral-oral route
  • Via saliva especially in developed countries[6]
  • Fecal-oral route
  • Fecal contamination of water and food may be the source of infection especially in developing countries[6]
  • Iatrogenic
  • Via tubes and endoscopes that have been in contact with the gastric mucosa of one individual are used for another patient
  • Between patient and staff especially among endoscopists and gastroenterologists
  • Motility of H. pylori (The corkscrew motility is due to its multiple flagella and spiral shape)
  • Chemotaxis
  • Environmental sensing
  • Acid resistance
  • Iron acquisition
  • H. pylori primarily colonizes the gastric mucosa and areas of gastric metaplasia; it has also been detected in the oral cavity/dental plaque, though the clinical significance of extragastric detection is uncertain.
Pathogenesis

Pathogenesis

  • The pathogenesis involves four important steps. They are:
  • Adhesion of H. pylori to host cell
  • Alteration of gastric acid secretion (increased in antral-predominant gastritis; decreased in corpus-predominant gastritis/pangastritis)[11]
  • Colonization
  • Inflammation

For further information on pathogenesis please click here

Factors Associated With Pathogenesis

Factors Associated With H. pylori Pathogenesis
Bacterial Host Environmental
Flagella Immune response to H. pylori
Bacterial enzymes
Hormonal and acid homeostasis changes
Bacterial Virulence factors
  • CagA
  • Outer inflammatory protein A (OipA)
  • Duodenal ulcer promoting gene A (dupA)
  • Blood group antigen binding adhesion A (BabA)
  • RNA polymerase Ξ²-subunit (RpoB)
  • Vacuolating cytotoxin (VacA)

1: Bacterial factors

A. Flagella

H. pylori propels through the mucus layer with the help of flagella and adheres to the gastric epithelial cells through fimbriae which are the extension of bacterial cytoplasm.

B. Bacterial enzymes

The bacterial enzymes associated with pathogenesis of H. pylori infection include:[16]

C. Bacterial Virulence factors

The cytotoxin-associated gene (Cag) pathogenecity island (PAI) and cytotoxin-associated gene A (cagA)

  • Large amounts of the pro-inflammatory cytokine interleukin-8 are expressed in H. pylori strains with CagPaI.
  • The protein CagA is encoded by CagA gene and type IV bacterial secretion system (T4SS) is encoded by CagPAI.
  • Type IV bacterial secretion apparatus helps in translocation of CagA into host target cells and stimulates epithelial cell pro-inflammatory cytokine expression and gastric inflammation
  • CagA undergoes phosphorylation in host target cells

The following are the bacterial virulence factors associated with H. pylori pathogenesis:

CagA

Outer inflammatory protein A (OipA)

Duodenal ulcer promoting gene A (dupA)

This gene is associated with duodenal ulceration but appeared to protect from gastric cancer in patients from columbia, Japan and South Korea.[33]

Blood group antigen binding adhesion A (BabA)

The RNA polymerase Ξ²-subunit (RpoB)

  • The RpoBThr is associated with increased secretion of IL-8 from MKN45 cells compared to RpoBAla.
  • H. pylori strains possessing RpoBThr is seen in 67.6% of East Asians and hence associated with increased risk of development of more severe gastroduodenal diseases.[36]

The vacuolating cytotoxin (VacA)

  • VacA is an exotoxin which is associated with cellular damage rather than pro-inflammatory cytokine release.[37]
  • The active forms of VacA are associated with increased risk of gastric carcinoma

2. Host genetic susceptibility

The risk of gastric carcinoma increases due toΒ :[38][39]

A.The immune response to H.Pylori

The innate immune response

The acquired immune response

B. Hormonal changes and acid homeostasis changes

Somatostatin and gastrin changes

3. Environmental cofactors

The environmental co-factors associated with H. pylori are:

Gross pathology

On gross pathology, H. pylori infection is associated with thickened gastric folds and erythema.[58]

Microscopic pathology

The microscopic pathology depends on the the following stages:[59]

Acute H.pylori infection

  • Most of the initial H. pylori colonization occur during childhood but new infections may occur in adults occasionally.[60][61]
  • Associated with transient profound gastric hypochlorhydria

Microscopic pathology

Chronic H.pylori infection

  • Chronic antral predominant inflammation:
  • Chronic corpus-predominant or pangastritis

Microscopic pathology

Pathogenesis of H.pylori Infection

Pathogenesis of H.pylori Infection

{{#ev:youtube|7NIXpTcQGYY}}

References

References

  1. ↑ Brown LM (2000). “Helicobacter pylori: epidemiology and routes of transmission”. Epidemiol Rev. 22 (2): 283–97. PMIDΒ 11218379.
  2. ↑ Cave DR (1997). “How is Helicobacter pylori transmitted?”. Gastroenterology. 113 (6 Suppl): S9–14. PMIDΒ 9394753.
  3. ↑ Transmission http://www.who.int/bulletin/archives/79(5)455.pdf (2001) Accessed on December 27, 2016
  4. ↑ Chey WD, Howden CW, Moss SF, Morgan DR, Greer KB, Grover S; et al. (2024). “ACG Clinical Guideline: Treatment of Helicobacter pylori Infection”. Am J Gastroenterol. 119 (9): 1730–1753. doi:10.14309/ajg.0000000000002968. PMIDΒ 39626064 Check |pmid= value (help).
  5. ↑ Duan M, Li Y, Liu J, Zhang W, Dong Y, Han Z; et al. (2023). “Transmission routes and patterns of helicobacter pylori”. Helicobacter. 28 (1): e12945. doi:10.1111/hel.12945. PMIDΒ 36645421 Check |pmid= value (help).
  6. ↑ 6.0 6.1 6.2 Das JC, Paul N (2007). “Epidemiology and pathophysiology of Helicobacter pylori infection in children”. Indian J Pediatr. 74 (3): 287–90. PMIDΒ 17401270.
  7. ↑ Thrift AP, Wenker TN, El-Serag HB (2023). “Global burden of gastric cancer: epidemiological trends, risk factors, screening and prevention”. Nat Rev Clin Oncol. 20 (5): 338–349. doi:10.1038/s41571-023-00747-0. PMIDΒ 36959359 Check |pmid= value (help).
  8. ↑ Kamangar F, Dawsey SM, Blaser MJ, Perez-Perez GI, Pietinen P, Newschaffer CJ; et al. (2006). “Opposing risks of gastric cardia and noncardia gastric adenocarcinomas associated with Helicobacter pylori seropositivity”. J Natl Cancer Inst. 98 (20): 1445–52. doi:10.1093/jnci/djj393. PMIDΒ 17047193.
  9. ↑ Farinha P, Gascoyne RD (2005). “Helicobacter pylori and MALT lymphoma”. Gastroenterology. 128 (6): 1579–605. doi:10.1053/j.gastro.2005.03.083. PMIDΒ 15887153.
  10. ↑ El Tekle G, Garrett WS (2023). “Bacteria in cancer initiation, promotion and progression”. Nat Rev Cancer. 23 (9): 600–618. doi:10.1038/s41568-023-00594-2. PMIDΒ 37400581 Check |pmid= value (help).
  11. ↑ 11.0 11.1 Lanas A, Chan FKL (2017). “Peptic ulcer disease”. Lancet. 390 (10094): 613–624. doi:10.1016/S0140-6736(16)32404-7. PMIDΒ 28242110.
  12. ↑ 12.0 12.1 Atherton JC (2006). “The pathogenesis of Helicobacter pylori-induced gastro-duodenal diseases”. Annu Rev Pathol. 1: 63–96. doi:10.1146/annurev.pathol.1.110304.100125. PMIDΒ 18039108.
  13. ↑ Malfertheiner P, Camargo MC, El-Omar E, Liou JM, Peek R, Schulz C; et al. (2023). “Helicobacter pylori infection”. Nat Rev Dis Primers. 9 (1): 19. doi:10.1038/s41572-023-00431-8. PMIDΒ 37081005 Check |pmid= value (help).
  14. ↑ Sundar R, Nakayama I, Markar SR, Shitara K, van Laarhoven HWM, Janjigian YY; et al. (2025). “Gastric cancer”. Lancet. 405 (10494): 2087–2102. doi:10.1016/S0140-6736(25)00052-2. PMIDΒ 40319897 Check |pmid= value (help).
  15. ↑ Wizenty J, Sigal M (2025). “Helicobacter pylori, microbiota and gastric cancer – principles of microorganism-driven carcinogenesis”. Nat Rev Gastroenterol Hepatol. 22 (5): 296–313. doi:10.1038/s41575-025-01042-2.
  16. ↑ Smoot DT (1997). “How does Helicobacter pylori cause mucosal damage? Direct mechanisms”. Gastroenterology. 113 (6 Suppl): S31–4, discussion S50. PMIDΒ 9394757.
  17. ↑ Berstad K, SjΓΆdahl R, Berstad A (1994). “Phospholipase A2 activity in gastric juice from patients with active and H. pylori-eradicated healed duodenal ulcer”. Aliment Pharmacol Ther. 8 (2): 175–80. PMIDΒ 8038348.
  18. ↑ Mauch F, Bode G, Ditschuneit H, Malfertheiner P (1993). “Demonstration of a phospholipid-rich zone in the human gastric epithelium damaged by Helicobacter pylori”. Gastroenterology. 105 (6): 1698–704. PMIDΒ 8253346.
  19. ↑ Wen Y, Marcus EA, Matrubutham U, Gleeson MA, Scott DR, Sachs G (2003). “Acid-adaptive genes of Helicobacter pylori”. Infect Immun. 71 (10): 5921–39. PMCΒ 201084. PMIDΒ 14500513.
  20. ↑ McGowan CC, Necheva AS, Forsyth MH, Cover TL, Blaser MJ (2003). “Promoter analysis of Helicobacter pylori genes with enhanced expression at low pH”. Mol Microbiol. 48 (5): 1225–39. PMIDΒ 12787351.
  21. ↑ Smoot DT, Mobley HL, Chippendale GR, Lewison JF, Resau JH (1990). “Helicobacter pylori urease activity is toxic to human gastric epithelial cells”. Infect Immun. 58 (6): 1992–4. PMCΒ 258755. PMIDΒ 2341188.
  22. ↑ Micots I, Augeron C, Laboisse CL, Muzeau F, MΓ©graud F (1993). “Mucin exocytosis: a major target for Helicobacter pylori”. J Clin Pathol. 46 (3): 241–5. PMCΒ 501178. PMIDΒ 8463418.
  23. ↑ Weeks DL, Eskandari S, Scott DR, Sachs G (2000). “A H+-gated urea channel: the link between Helicobacter pylori urease and gastric colonization”. Science. 287 (5452): 482–5. PMIDΒ 10642549.
  24. ↑ Matsui T, Matsukawa Y, Sakai T, Nakamura K, Aoike A, Kawai K (1995). “Effect of ammonia on cell-cycle progression of human gastric cancer cells”. Eur J Gastroenterol Hepatol. 7 Suppl 1: S79–81. PMIDΒ 8574744.
  25. ↑ Selbach M, Moese S, Hauck CR, Meyer TF, Backert S (2002). “Src is the kinase of the Helicobacter pylori CagA protein in vitro and in vivo”. J Biol Chem. 277 (9): 6775–8. doi:10.1074/jbc.C100754200. PMIDΒ 11788577.
  26. ↑ Stein M, Bagnoli F, Halenbeck R, Rappuoli R, Fantl WJ, Covacci A (2002). “c-Src/Lyn kinases activate Helicobacter pylori CagA through tyrosine phosphorylation of the EPIYA motifs”. Mol Microbiol. 43 (4): 971–80. PMIDΒ 11929545.
  27. ↑ Argent RH, Kidd M, Owen RJ, Thomas RJ, Limb MC, Atherton JC (2004). “Determinants and consequences of different levels of CagA phosphorylation for clinical isolates of Helicobacter pylori”. Gastroenterology. 127 (2): 514–23. PMIDΒ 15300584.
  28. ↑ Azuma T, Yamakawa A, Yamazaki S, Fukuta K, Ohtani M, Ito Y; et al. (2002). “Correlation between variation of the 3′ region of the cagA gene in Helicobacter pylori and disease outcome in Japan”. J Infect Dis. 186 (11): 1621–30. doi:10.1086/345374. PMIDΒ 12447739.
  29. ↑ Yamaoka Y, Kodama T, Kashima K, Graham DY, Sepulveda AR (1998). “Variants of the 3′ region of the cagA gene in Helicobacter pylori isolates from patients with different H. pylori-associated diseases”. J Clin Microbiol. 36 (8): 2258–63. PMCΒ 105028. PMIDΒ 9666002.
  30. ↑ Yamaoka Y, Kikuchi S, el-Zimaity HM, Gutierrez O, Osato MS, Graham DY (2002). “Importance of Helicobacter pylori oipA in clinical presentation, gastric inflammation, and mucosal interleukin 8 production”. Gastroenterology. 123 (2): 414–24. PMIDΒ 12145793.
  31. ↑ Yamaoka Y, Ojo O, Fujimoto S, Odenbreit S, Haas R, Gutierrez O; et al. (2006). “Helicobacter pylori outer membrane proteins and gastroduodenal disease”. Gut. 55 (6): 775–81. doi:10.1136/gut.2005.083014. PMCΒ 1856239. PMIDΒ 16322107.
  32. ↑ Yamaoka Y, Kwon DH, Graham DY (2000). “A M(r) 34,000 proinflammatory outer membrane protein (oipA) of Helicobacter pylori”. Proc Natl Acad Sci U S A. 97 (13): 7533–8. doi:10.1073/pnas.130079797. PMCΒ 16580. PMIDΒ 10852959.
  33. ↑ Zhang Z, Zheng Q, Chen X, Xiao S, Liu W, Lu H (2008). “The Helicobacter pylori duodenal ulcer promoting gene, dupA in China”. BMC Gastroenterol. 8: 49. doi:10.1186/1471-230X-8-49. PMCΒ 2584642. PMIDΒ 18950522.
  34. ↑ Ilver D, Arnqvist A, Ogren J, Frick IM, Kersulyte D, Incecik ET; et al. (1998). “Helicobacter pylori adhesin binding fucosylated histo-blood group antigens revealed by retagging”. Science. 279 (5349): 373–7. PMIDΒ 9430586.
  35. ↑ Gerhard M, Lehn N, Neumayer N, BorΓ©n T, Rad R, Schepp W; et al. (1999). “Clinical relevance of the Helicobacter pylori gene for blood-group antigen-binding adhesin”. Proc Natl Acad Sci U S A. 96 (22): 12778–83. PMCΒ 23096. PMIDΒ 10535999.
  36. ↑ Lee KH, Cho MJ, Yamaoka Y, Graham DY, Yun YJ, Woo SY; et al. (2004). “Alanine-threonine polymorphism of Helicobacter pylori RpoB is correlated with differential induction of interleukin-8 in MKN45 cells”. J Clin Microbiol. 42 (8): 3518–24. doi:10.1128/JCM.42.8.3518-3524.2004. PMCΒ 497570. PMIDΒ 15297492.
  37. ↑ Papini E, Zoratti M, Cover TL (2001). “In search of the Helicobacter pylori VacA mechanism of action”. Toxicon. 39 (11): 1757–67. PMIDΒ 11595638.
  38. ↑ El-Omar EM, Carrington M, Chow WH, McColl KE, Bream JH, Young HA; et al. (2000). “Interleukin-1 polymorphisms associated with increased risk of gastric cancer”. Nature. 404 (6776): 398–402. doi:10.1038/35006081. PMIDΒ 10746728.
  39. ↑ Machado JC, Figueiredo C, Canedo P, Pharoah P, Carvalho R, Nabais S; et al. (2003). “A proinflammatory genetic profile increases the risk for chronic atrophic gastritis and gastric carcinoma”. Gastroenterology. 125 (2): 364–71. PMIDΒ 12891537.
  40. ↑ 40.0 40.1 George JT, Boughan PK, Karageorgiou H, Bajaj-Elliott M (2003). “Host anti-microbial response to Helicobacter pylori infection”. Mol Immunol. 40 (7): 451–6. PMIDΒ 14568391.
  41. ↑ Jung HC, Kim JM, Song IS, Kim CY (1997). “Helicobacter pylori induces an array of pro-inflammatory cytokines in human gastric epithelial cells: quantification of mRNA for interleukin-8, -1 alpha/beta, granulocyte-macrophage colony-stimulating factor, monocyte chemoattractant protein-1 and tumour necrosis factor-alpha”. J Gastroenterol Hepatol. 12 (7): 473–80. PMIDΒ 9257236.
  42. ↑ Netea MG, van der Graaf C, Van der Meer JW, Kullberg BJ (2004). “Toll-like receptors and the host defense against microbial pathogens: bringing specificity to the innate-immune system”. J Leukoc Biol. 75 (5): 749–55. doi:10.1189/jlb.1103543. PMIDΒ 15075354.
  43. ↑ Isomoto H, Mukae H, Ishimoto H, Date Y, Nishi Y, Inoue K; et al. (2004). “Elevated concentrations of alpha-defensins in gastric juice of patients with Helicobacter pylori infection”. Am J Gastroenterol. 99 (10): 1916–23. doi:10.1111/j.1572-0241.2004.40334.x. PMIDΒ 15447750.
  44. ↑ Ernst PB, Gold BD (2000). “The disease spectrum of Helicobacter pylori: the immunopathogenesis of gastroduodenal ulcer and gastric cancer”. Annu Rev Microbiol. 54: 615–40. doi:10.1146/annurev.micro.54.1.615. PMIDΒ 11018139.
  45. ↑ Allen LA, Schlesinger LS, Kang B (2000). “Virulent strains of Helicobacter pylori demonstrate delayed phagocytosis and stimulate homotypic phagosome fusion in macrophages”. J Exp Med. 191 (1): 115–28. PMCΒ 2195807. PMIDΒ 10620610.
  46. ↑ Schwartz JT, Allen LA (2006). “Role of urease in megasome formation and Helicobacter pylori survival in macrophages”. J Leukoc Biol. 79 (6): 1214–25. doi:10.1189/jlb.0106030. PMCΒ 1868427. PMIDΒ 16543403.
  47. ↑ Appelmelk BJ, Simoons-Smit I, Negrini R, Moran AP, Aspinall GO, Forte JG; et al. (1996). “Potential role of molecular mimicry between Helicobacter pylori lipopolysaccharide and host Lewis blood group antigens in autoimmunity”. Infect Immun. 64 (6): 2031–40. PMCΒ 174033. PMIDΒ 8675304.
  48. ↑ Amedei A, Bergman MP, Appelmelk BJ, Azzurri A, Benagiano M, Tamburini C; et al. (2003). “Molecular mimicry between Helicobacter pylori antigens and H+, K+ –adenosine triphosphatase in human gastric autoimmunity”. J Exp Med. 198 (8): 1147–56. doi:10.1084/jem.20030530. PMCΒ 2194239. PMIDΒ 14568977.
  49. ↑ Bamford KB, Fan X, Crowe SE, Leary JF, Gourley WK, Luthra GK; et al. (1998). “Lymphocytes in the human gastric mucosa during Helicobacter pylori have a T helper cell 1 phenotype”. Gastroenterology. 114 (3): 482–92. PMIDΒ 9496938.
  50. ↑ D’Elios MM, Manghetti M, De Carli M, Costa F, Baldari CT, Burroni D; et al. (1997). “T helper 1 effector cells specific for Helicobacter pylori in the gastric antrum of patients with peptic ulcer disease”. J Immunol. 158 (2): 962–7. PMIDΒ 8993017.
  51. ↑ Fan XJ, Chua A, Shahi CN, McDevitt J, Keeling PW, Kelleher D (1994). “Gastric T lymphocyte responses to Helicobacter pylori in patients with H pylori colonisation”. Gut. 35 (10): 1379–84. PMCΒ 1375009. PMIDΒ 7959191.
  52. ↑ Lehmann FS, Terracciano L, Carena I, Baeriswyl C, Drewe J, Tornillo L; et al. (2002). “In situ correlation of cytokine secretion and apoptosis in Helicobacter pylori-associated gastritis”. Am J Physiol Gastrointest Liver Physiol. 283 (2): G481–8. doi:10.1152/ajpgi.00422.2001. PMIDΒ 12121897.
  53. ↑ Lundgren A, Suri-Payer E, Enarsson K, Svennerholm AM, Lundin BS (2003). “Helicobacter pylori-specific CD4+ CD25high regulatory T cells suppress memory T-cell responses to H. pylori in infected individuals”. Infect Immun. 71 (4): 1755–62. PMCΒ 152046. PMIDΒ 12654789.
  54. ↑ Moss SF, Legon S, Bishop AE, Polak JM, Calam J (1992). “Effect of Helicobacter pylori on gastric somatostatin in duodenal ulcer disease”. Lancet. 340 (8825): 930–2. PMIDΒ 1357347.
  55. ↑ Odum L, Petersen HD, Andersen IB, Hansen BF, Rehfeld JF (1994). “Gastrin and somatostatin in Helicobacter pylori infected antral mucosa”. Gut. 35 (5): 615–8. PMCΒ 1374743. PMIDΒ 7911115.
  56. ↑ Arebi N, Healey ZV, Bliss PW, Ghatei M, Van Noorden S, Playford RJ; et al. (2002). “Nitric oxide regulates the release of somatostatin from cultured gastric rabbit primary D-cells”. Gastroenterology. 123 (2): 566–76. PMIDΒ 12145809.
  57. ↑ 57.0 57.1 Guo YS, Cheng JZ, Jin GF, Gutkind JS, Hellmich MR, Townsend CM (2002). “Gastrin stimulates cyclooxygenase-2 expression in intestinal epithelial cells through multiple signaling pathways. Evidence for involvement of ERK5 kinase and transactivation of the epidermal growth factor receptor”. J Biol Chem. 277 (50): 48755–63. doi:10.1074/jbc.M209016200. PMIDΒ 12239223.
  58. ↑ H.pylori infection https://librepathology.org/wiki/Helicobacter_gastritis (May,2016) Accessed on January 4, 2017
  59. ↑ Faigel DO, Furth EE, Childs M, Goin J, Metz DC (1996). “Histological predictors of active Helicobacter pylori infection”. Dig Dis Sci. 41 (5): 937–43. PMIDΒ 8625766.
  60. ↑ Sobala GM, Crabtree JE, Dixon MF, Schorah CJ, Taylor JD, Rathbone BJ; et al. (1991). “Acute Helicobacter pylori infection: clinical features, local and systemic immune response, gastric mucosal histology, and gastric juice ascorbic acid concentrations”. Gut. 32 (11): 1415–8. PMCΒ 1379180. PMIDΒ 1752479.
  61. ↑ Dixon MF (1995). “Histological responses to Helicobacter pylori infection: gastritis, atrophy and preneoplasia”. Baillieres Clin Gastroenterol. 9 (3): 467–86. PMIDΒ 8563048.

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Fahad Hasan, M.D.[2] Yamuna Kondapally, M.B.B.S[3]